Catalpol improves impaired neurovascular unit in ischemic stroke rats via enhancing VEGF-PI3K/AKT and VEGF-MEK1/2/ERK1/2 signaling
| Autor: | Ji-Fen Zhang, Hong-Jin Wang, Yi-jin Chen, Yi Chen, Qiang Xue, Shi-qi Yu, Shan Feng, Bao-xiang Jiang, Xiao-yu Xu, Huijing Ren, Xiao-gang Xu, Yue Yin, Hai-feng Ran |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Vascular Endothelial Growth Factor A
Angiogenesis MAP Kinase Signaling System Iridoid Glucosides Pharmacology Article Pathogenesis chemistry.chemical_compound Phosphatidylinositol 3-Kinases Medicine Animals Pharmacology (medical) Protein kinase B PI3K/AKT/mTOR pathway Ischemic Stroke business.industry Neurogenesis General Medicine Catalpol Rats Vascular endothelial growth factor chemistry business Proto-Oncogene Proteins c-akt Homeostasis |
| Zdroj: | Acta Pharmacol Sin |
| ISSN: | 1745-7254 |
| Popis: | Neurovascular unit (NVU) is organized multi-cellular and multi-component networks that are essential for brain health and brain homeostasis maintaining. Neurovascular unit dysfunction is the central pathogenesis process of ischemic stroke. Thus integrated protection of NVU holds great therapeutic potential for ischemic stroke. Catalpol, classified into the iridoid monosaccharide glycoside, is the main active ingredient of the radix from traditional Chinese medicine, Rehmannia glutinosa Libosch, that exhibits protective effects in several brain-related diseases. In the present study, we investigated whether catalpol exerted protective effects for NVU in ischemic stroke and the underlying mechanisms. MCAO rats were administered catalpol (2.5, 5.0, 10.0 mg·kg(−1)·d(−1), i.v.) for 14 days. We showed that catalpol treatment dose-dependently reduced the infarction volume and significantly attenuated neurological deficits score in MCAO rats. Furthermore, catalpol treatment significantly ameliorated impaired NVU in ischemic region by protecting vessel-neuron-astrocyte structures and morphology, and promoting angiogenesis and neurogenesis to replenish lost vessels and neurons. Moreover, catalpol treatment significantly increased the expression of vascular endothelial growth factor (VEGF) through up-regulating PI3K/AKT signaling, followed by increasing FAK and Paxillin and activating PI3K/AKT and MEK1/2/ERK1/2 pathways. The protective mechanisms of catalpol were confirmed in an in vitro three-dimensional NVU model subjected to oxygen-glucose deprivation. In conclusion, catalpol protects NVU in ischemic region via activation of PI3K/AKT signaling and increased VEGF production; VEGF further enhances PI3K/AKT and MEK1/2/ERK1/2 signaling, which may trigger a partly feed-forward loop to protect NVU from ischemic stroke. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink